Skip to main content
. 2022 Jan 27;11(2):249. doi: 10.3390/antiox11020249

Table 3.

Cardiac energy metabolism assessment.

Variables C (n = 8) I (n = 8) IJ2 (n = 8) IJ4 (n = 8)
Phosphofructokinase (nmol/g) 148 ± 29 355 ± 78 *# 340 ± 99 *# 134 ± 62
Pyruvate dehydrogenase complex (nmol/g) 282 ± 30 212 ± 56 244 ± 35 186 ± 37 *
Lactate dehydrogenase (nmol/g) 61 ± 10 92 ± 28 * 78 ± 14 91 ± 24 *
β-Hydroxyacyl-CoA dehydrogenase (nmol/mg) 26 ± 5 10 ± 3 * 8 ± 2 * 9 ± 3 *
Citrate synthase (nmol/g) 31 ± 6 16 ± 3 * 17 ± 3* 16 ± 3 *
Complex I (NADH dehydrogenase) (nmol/mg) 10 ± 1 6 ± 1 * 5 ± 1 * 5 ± 1 *
Complex II (Succinate dehydrogenase) (nmol/mg) 4.87 ± 0.88 2.75 ± 0.54 * 2.88 ± 0.98 * 2.55 ± 0.48 *
ATP synthase (nmol/mg) 30 ± 5 18 ± 4 * 23 ± 4 16 ± 4 *

C: control animals; I: infarcted animals; IJ2: infarcted animals supplemented with jaboticaba 2%; IJ4: infarcted animals supplemented with jaboticaba 4%. Data are expressed as the mean ± SD. * p < 0.05 versus C; # p < 0.05 versus IJ4.